Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings.
Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Iwashiro S, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S. Ikeda T, et al. Among authors: iwashiro s. J Thromb Thrombolysis. 2019 Nov;48(4):653-660. doi: 10.1007/s11239-019-01934-6. J Thromb Thrombolysis. 2019. PMID: 31432451 Free PMC article. Clinical Trial.
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan.
Miyamoto S, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Murakawa Y, Iwashiro S, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S. Miyamoto S, et al. Among authors: iwashiro s. J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104584. doi: 10.1016/j.jstrokecerebrovasdis.2019.104584. Epub 2020 Jan 23. J Stroke Cerebrovasc Dis. 2020. PMID: 31983518 Free article.
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Iwashiro S, Okayama Y, Sunaya T, Hirano K, Hayasaki T. Ikeda T, et al. Among authors: iwashiro s. PLoS One. 2021 Jun 11;16(6):e0251325. doi: 10.1371/journal.pone.0251325. eCollection 2021. PLoS One. 2021. PMID: 34115769 Free PMC article.
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT).
Fukuda I, Hirayama A, Kawasugi K, Kobayashi T, Maeda H, Nakamura M, Nakanishi N, Yamada N, Tajima T, Iwashiro S, Okayama Y, Sunaya T, Hirano K, Hayasaki T. Fukuda I, et al. Among authors: iwashiro s. TH Open. 2021 Oct 7;5(4):e521-e532. doi: 10.1055/a-1664-1164. eCollection 2021 Oct. TH Open. 2021. PMID: 34877450 Free PMC article.